Protalix Biotherapeutics, Inc. (PLX)
2.70
-0.10
(-3.57%)
USD |
NYAM |
Feb 10, 16:00
2.75
+0.05
(+1.85%)
Pre-Market: 20:00
Protalix Biotherapeutics EPS Diluted (Quarterly) : 0.0291 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | -0.736 |
| OraSure Technologies, Inc. | -0.1878 |
| PAVmed, Inc. | -8.807 |
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.355M |
| Revenue (Quarterly) | 17.85M |
| Total Expenses (Quarterly) | 15.50M |
| Enterprise Value | 195.94M |
| Gross Profit Margin (Quarterly) | 53.37% |
| Profit Margin (Quarterly) | 13.19% |
| Earnings Yield | 2.57% |
| Operating Earnings Yield | 3.00% |
| Normalized Earnings Yield | 2.574 |